Issue link: https://viewer.e-digitaledition.com/i/64389
COVER FEATURE THE CURRENTS OF NEUROMODULATION SINCE THE INFANCY of the field of neuromodulation, specialists have recognized the clinical potential of guiding and redirecting the electrical signals in the brain. Promise holds that, with every system, sensation and abnormality controlled or affected in even the slightest sense by the electrical network centrally located in the brain, functional neurosurgeons could positively affect any number of acute and chronic patient concerns by manipulating the brain's electrical signals. The modern era of neuromodulation dates back to the 1960s, when deep brain stimulation was applied as a treatment for intrac- table pain. That evolved into spinal cord stimulation by 1967, when American neurosurgeon Dr. C. Norman Shealy built and implanted the first neuromodulatory devices, which he described as dorsal column stimulators, to treat intractable pain. The early mechanisms, however, suffered from complications related to spinal cord compression and cerebrospinal fluid leakages. A second generation of neurostimulation technology involved less invasive approaches in which electrodes could be placed outside subarachnoid spaces. Today, the delicate planning of electrode implantation and the procedures themselves are based on the introduction of computer modeling to the field of neuromodulation. While the basic idea of interrupting electrical signals remains the same, the work of Dr. Jan Holsheimer, a neurophysiologist in the Netherlands, enhanced the medical community's insight into the ideal targets and placement points for providing stimulation to specific areas in the brain and spine. of pain signals without injuring the nerves themselves. The new generation of technology — namely the AdaptiveStim feature of the RestoreSensor Neurostimulator — height- ens the device's ability to relieve patients' pain. With previous neurostimulator mod- els, Dr. Falowski estimates that up to 70% of patients experienced difficulty completely integrating the device into their daily lives with positional changes. Whenever the patients moved or changed their body positioning, the device's electrode would shift slightly closer to or farther from the spinal cord, which, in turn, would alter the level of stimulation delivered to the target area. The patient could readjust the device and the stimulation to return both to their starting points, but the process amounted to an interruption of his or her pain relief. "With the new technology, the implant actually senses the patient's position — whether standing, sitting or lying down," Dr. Falowski says. "It changes the stimula- tion as the patient changes position, and the implant learns what the patient likes as he or she moves." In treating patients' chronic and intrac- table pain, Dr. Falowski most commonly places the device in the buttock. First, he makes a small incision in the back to access the thoracic spine. He then removes a piece of the spine's bony anatomy (laminectomy) and places an electrode directly on the spinal cord. A series of wires connect the electrode to the implant in the buttocks. Above: Dr. Falowski using the neurostimulator device 8 | Eastern Pennsylvania/NW New Jersey MD NEWS ■ MDNEWS.COM

